PAVmed (PAVM) Competitors $0.65 0.00 (0.00%) As of 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAVM vs. XAIR, PTHL, CODX, BSGM, FEMY, NXGL, VVOS, PETV, NRXS, and NEPHShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Beyond Air (XAIR), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Co-Diagnostics (CODX), BioSig Technologies (BSGM), Femasys (FEMY), NEXGEL (NXGL), Vivos Therapeutics (VVOS), PetVivo (PETV), NeurAxis (NRXS), and Nephros (NEPH). These companies are all part of the "medical equipment" industry. PAVmed vs. Beyond Air Pheton Holdings Ltd Class A Ordinary Shares Co-Diagnostics BioSig Technologies Femasys NEXGEL Vivos Therapeutics PetVivo NeurAxis Nephros PAVmed (NASDAQ:PAVM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability. Does the media prefer PAVM or XAIR? In the previous week, Beyond Air had 1 more articles in the media than PAVmed. MarketBeat recorded 1 mentions for Beyond Air and 0 mentions for PAVmed. PAVmed's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score. Company Overall Sentiment PAVmed Neutral Beyond Air Neutral Which has more risk & volatility, PAVM or XAIR? PAVmed has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.17, suggesting that its share price is 117% less volatile than the S&P 500. Does the MarketBeat Community favor PAVM or XAIR? PAVmed received 155 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 66.12% of users gave PAVmed an outperform vote. CompanyUnderperformOutperformPAVmedOutperform Votes20366.12% Underperform Votes10433.88% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Which has preferable valuation and earnings, PAVM or XAIR? Beyond Air has lower revenue, but higher earnings than PAVmed. Beyond Air is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$4.03M1.81-$64.18M-$4.35-0.15Beyond Air$1.16M27.20-$60.24M-$1.41-0.31 Do institutionals & insiders have more ownership in PAVM or XAIR? 19.9% of PAVmed shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 11.3% of PAVmed shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate PAVM or XAIR? PAVmed presently has a consensus target price of $19.00, indicating a potential upside of 2,778.79%. Beyond Air has a consensus target price of $3.67, indicating a potential upside of 739.05%. Given PAVmed's stronger consensus rating and higher possible upside, research analysts plainly believe PAVmed is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is PAVM or XAIR more profitable? PAVmed has a net margin of 602.97% compared to Beyond Air's net margin of -2,369.17%. PAVmed's return on equity of 0.00% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets PAVmed602.97% N/A -92.36% Beyond Air -2,369.17%-227.29%-106.51% SummaryPAVmed beats Beyond Air on 9 of the 17 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.25M$4.83B$5.39B$9.14BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-0.1526.1388.1017.53Price / Sales1.8161.291,285.4080.11Price / CashN/A50.8936.6032.90Price / Book-0.207.894.954.67Net Income-$64.18M$13.87M$117.96M$224.69M7 Day Performance10.18%4.06%2.49%3.32%1 Month Performance13.40%11.17%3.44%5.36%1 Year Performance-75.74%33.28%27.06%22.59% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.0056 of 5 stars$0.65flat$19.00+2,823.1%-76.1%$7.20M$4.03M-0.1590XAIRBeyond Air4.3191 of 5 stars$0.36-6.3%$3.67+911.2%-68.0%$26.18M$2.34M-0.2670News CoveragePTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.90-1.0%N/AN/A$25.67M$572,291.000.0011Positive NewsGap DownCODXCo-Diagnostics3.7248 of 5 stars$0.76-8.2%$1.50+96.9%-34.8%$24.33M$7.32M-0.55100BSGMBioSig Technologies1.5644 of 5 stars$1.41-2.1%$2.75+95.0%-56.9%$24.30M$39,000.000.0050FEMYFemasys3.2878 of 5 stars$1.05-2.8%$10.00+852.4%+38.8%$24.04M$1.26M-1.3030NXGLNEXGEL0.4168 of 5 stars$3.53+4.1%N/A+46.3%$23.97M$6.73M-6.0910VVOSVivos Therapeutics1.7117 of 5 stars$4.85-4.5%$6.30+29.9%-11.7%$23.45M$14.58M-0.85160Positive NewsPETVPetVivoN/A$0.95+1.9%N/A-34.9%$19.55M$1.05M-1.9820NRXSNeurAxisN/A$2.54+2.0%N/A+16.7%$17.73M$2.46M-1.3819News CoverageGap UpNEPHNephros2.6633 of 5 stars$1.51+0.2%$5.00+230.3%-53.7%$15.96M$13.55M-16.8230 Related Companies and Tools Related Companies Beyond Air Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors Co-Diagnostics Competitors BioSig Technologies Competitors Femasys Competitors NEXGEL Competitors Vivos Therapeutics Competitors PetVivo Competitors NeurAxis Competitors Nephros Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PAVM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PAVM Stock Alerts